• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
the role of the drug regulatory agencies about the interaction
the role of the drug regulatory agencies about the interaction

... the FDA(2) calls for a critical appraisal of their place in therapy, which is crucial to be addressed especially in haemorrhagic high-risk patients.  Finally, from a practical point of view, both clopidogrel and omeprazole are very useful drugs when used appropriately, being a first-line treatment ...
Evaluating drugs used to treat fibromyalgia
Evaluating drugs used to treat fibromyalgia

... Welcome medication they see fit to treat a person’s condition. It is important to note that although only these three drugs are approved by the FDA specifically for fibromyalgia, the approval process is lengthy and expensive for manufacturing companies, so older drugs that are already approved for ...
Bioavailability The in
Bioavailability The in

... 3-Physical methods A variety of methods which utilize physical properties can be used to calculate AUCs For example, if plasma conc. profiles are plotted on smooth paper, these can be cut out and weighed on an electronic balance. ...
Antihypertensive Drugs - coursewareobjects.com
Antihypertensive Drugs - coursewareobjects.com

... no longer adequately reflected the current range of pharmacologic alternatives or furnished the type of care dictated by the current level of scientific understanding of the disorder. In JNC 6individualized therapy was proposed as a more appropriate treatment strategy, because it allowed specific pa ...
Foreign Pharmacy Graduate Equivalency Examination
Foreign Pharmacy Graduate Equivalency Examination

... 4. Supply and demand (health care services, medicines/drug products, economic modeling, etc) 5. Economic evaluation of medicines and therapy (quality of life, outcomes [therapeutic/clinical/humanistic/cost], pharmacoecononiic analyses, DUE/DUR programs, etc) B. Ethics/Jurisprudence 1. Jurisdiction: ...
Resource Manual
Resource Manual

... use them to help them “come down” from other drugs. The most commonly prescribed, and the most commonly abused by teens, are the benzodiazepines, such as Xanax, Valium, Ativan, and Klonopin. These drugs induce drowsiness and intense relaxation and reduce social inhibitions. When not used as prescrib ...
Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and
Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and

... than expected ranges, could therefore aid in avoiding drug resistance as well as unnecessary costs. In the case of PZA, the majority of our patients had concentrations within the target range, which is perhaps due to the wide reference range for PZA (20–50 μg /ml). The prevalence of low drug plasma ...
Sample pages 1 PDF
Sample pages 1 PDF

... actively being conceptualized and invented, and significant time is being devoted in both academia and industry to research this route of drug delivery [7]. The same review highlights that there are less than 50 registered products available for buccal/ sublingual delivery in the USA at its time of ...
Next Generation Therapeutics for Disorders of Complement
Next Generation Therapeutics for Disorders of Complement

... – Rapid, sustained, near complete suppression of hemolysis and complement activity  Received orphan drug designation from European Medicines Authority (EMA)  Phase 2: Regulatory clearance from FDA and ex-US agencies, Institutional Review Board (IRB) approvals received, site activation underway, do ...
- KoreaMed Synapse
- KoreaMed Synapse

... are those that should not be used because safety has not been established or there is concern for risk of serious adverse drug reactions in the given age groups.”[10] The dictionary definition of contraindication is 'sign that someone should not continue with a particular medicine or treatment becau ...
Amorphous solid dispersion method for improving oral
Amorphous solid dispersion method for improving oral

... bioavailability of sparingly water-soluble drugs. Drug particle size reduction improved the ...
Current Approaches for ADME Characterization of
Current Approaches for ADME Characterization of

... DAR2,4,&8 were only for cysteine conjugated mAbs correct? This my not bee the same for lysine or other amino acid conjugated ADCs (with cysteine conjugated mAbs the mAb will have reduced covelent bonds between LC & HC which may impact the PK in a very differnt manner than ADCs conjugated through oth ...
Orciprenaline Sulphate - EBL
Orciprenaline Sulphate - EBL

... Ephedrine hydrochloride helps to relieve the symptoms caused by asthma. It helps to relax the smooth muscles present in the lungs, this is turn allows the bronchial discharge to flow out from the bronchial tubes to generate more cough. Dosage: This medication should be taken 3 times a day, by mouth. ...
Therapeutic Drug Monitoring (TDM)
Therapeutic Drug Monitoring (TDM)

... constant in individuals, but decreases with age and when sodium intake is lowered. However, renal lithium clearance may vary greatly between patients and lithium dosage must, therefore, be adjusted on the basis of the plasma lithium concentration 6–12 hours post-dose. The plasma lithium should then ...
Full Text Article - European Journal of Pharmaceutical and Medical
Full Text Article - European Journal of Pharmaceutical and Medical

... result of deep dermal, subcutaneous and/or submucosal swelling.[4] It is typically non pitting, skin coloured or erythematous and occurs at areas where the skin is lax. It is generally self limiting but may sometimes result in respiratory tract obstruction, which can prove fatal.[1] Drug induced ang ...
Briefing Document: Reducing Preventable Harm to Patients with
Briefing Document: Reducing Preventable Harm to Patients with

... 2. Lack of knowledge or information regarding cross-sensitivity, i.e. which drugs are contraindicated or to be used with caution when an allergy is documented. 3. Lack of availability / accessibility of reliable information regarding a patient’s allergy history at the point of prescribing, dispensin ...
STRUCTURE OF THE MEDICAL PRESCRIPTION
STRUCTURE OF THE MEDICAL PRESCRIPTION

... Da tales doses № 10 in ampullis (D. t. d. № 10) = Dispense such doses 20 in number 5. SIGNATURA (MARK, LABEL) Notes are written in Bulgarian. The signature is the message intended for the patient. It provides instructions as to how the medicine should be taken by the patient. This information must b ...
Publication PDF
Publication PDF

... Thus, the legislation continues to reinforce the model of the FDA as the center of medical product innovation—a model that has prevailed for over half a century. For most of the FDA’s history, medicine and device development became increasingly national in scope, while data sharing among medical pr ...
Sustained release drug delivery system
Sustained release drug delivery system

... The advantages of administering a single dose of a drug that is released over an extended period of time, instead of numerous doses, have been obvious to the Pharmaceutical industry for some time. The desire to maintain a near-constant or uniform blood level of a drug often translates into better pa ...
Pharmacology and the Nursing Process, 4th ed. Lilley/Harrington
Pharmacology and the Nursing Process, 4th ed. Lilley/Harrington

... Inhibits protein and nucleic acid synthesis Used mainly for the treatment of active P. jirovecii pneumonia and for prophylaxis of P. jirovecii pneumonia in patients at high risk for initial or recurrent Pneumocystis infection, such as patients with HIV infection and AIDS Sometimes used to treat vari ...
Prescription Writing
Prescription Writing

... that had not been proven to be safe ...
The Medicare amendment adopted late last year contains a
The Medicare amendment adopted late last year contains a

... of a medicine to provide “efficacy” is still derived from randomized clinical trials and, under the current licensing regulations of major industrialized countries, the manufacturer must show clinical trial evidence from placebo-controlled trials. Thus, a sponsor must show absolute, not comparative, ...
Agrochemicals against Malaria, Sleeping Sickness, Leishmaniasis
Agrochemicals against Malaria, Sleeping Sickness, Leishmaniasis

... Leishmania donovani (Ld). Amastigotes of L. donovani strain MHOM/ET/67/L82 were grown in axenic culture at 37uC in SM medium [31] at pH 5.4 supplemented with 10% heatinactivated fetal bovine serum under an atmosphere of 5% CO2 in air. One hundred microlitres of culture medium with 105 amastigotes fr ...
FREE Sample Here
FREE Sample Here

... 2. Psychoactive drugs are those drugs that influence the functioning of the brain and hence our behavior. Some psychoactive drugs are licit (legal) and others are illicit (illegal). In the case of licit drugs, there is legal availability to the general public in the United States, though in the case ...
Basic Pharmacokinetics
Basic Pharmacokinetics

... times when we did not collect samples, we must linearize the plot by using semilog paper (Figure 2-9). For a drug with first-order elimination, the natural log of plasma concentration versus time plot is a straight line. Conversely, plots with zero-order elimination would be as shown in Figure 2-10. ...
< 1 ... 27 28 29 30 31 32 33 34 35 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report